Marco Marinucci - Mind the Bridge - Stanford - 2010
•Descargar como PPTX, PDF•
1 recomendación•407 vistas
![STATE OF ENTREPRENEURSHIP IN ITALY ,[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recomendados
Recomendados
Más contenido relacionado
La actualidad más candente
La actualidad más candente (18)
Destacado
Destacado (8)
Similar a Marco Marinucci - Mind the Bridge - Stanford - 2010
Similar a Marco Marinucci - Mind the Bridge - Stanford - 2010 (20)
Más de Burton Lee
Más de Burton Lee (20)
Último
Último (20)
Marco Marinucci - Mind the Bridge - Stanford - 2010
- 3. In Italy SMEs are 98% of the total
- 5. Primarily Services (67% of GDP), Manufacturing is only 24%
- 6. Innovative industries play a minor role (2-5%)
- 7. Strong family business vocation
- 8. “One man only at the helm.”
- 9. “Companies are life-long enterprises.”
- 10. “First get some revenue, and then invest.”
- 11. “Think real.” ITALY: INDUSTRY CONTRIBUTION TO GDP (2009) 2 Source: CrESIT 2010
- 13. Of the €4.5B invested yearly (avg. 2006-2008), approximately €70M went to early-stage investments (AIFI & PricewaterhouseCoopers 2008)
- 14. Only 186 start-ups were able to get funded in the last three years, with an average deal size of €0.5M to €1M (AIFI & PricewaterhouseCoopers 2008)
- 15. In H1 2009: 46 early stage deals (€56M invested) (AIFI & PricewaterhouseCoopers 2009)
- 16. Small size of the stock market does not help
- 17. The stock market capitalization to GDP ratio is lower than 60%, versus 140% in the United States and 170% in the United Kingdom (IMF & World Federation of Exchange)
- 18. The aforementioned lack of large companies makes the exit from investment difficult3
- 20. Cumulative R&D investments are €17B (4% of GDP), whose 30% from universities and 20% from public and non-profit (ICE, Cotec, Istat)
- 21. 400k scientific publication in the period 1998-2008 ranking 8th in the global classification (7th for number of citations) (Thomson Reuters, 2008)
- 22. Biotech: 750 clinical trials in progress during 2007 (Blossom-Assobiotec 2009)
- 23. Issues in turning research into business
- 24. Lack of efficient technology transfer offices
- 25. Universities do not offer incentives for lecturers to spin-off business initiatives
- 26. Scarcity of skilled executives with strong entrepreneurial skills
- 27. Italian scientists do not think business4
- 29. High mortality (“crisi del primo miglio”)
- 30. Bridging research into business
- 31. Mindset
- 33. Exit on the domestic market
- 34. Technology hot shots aspire to sell out to new economy “leviathans”
- 37. Selecting the best of breed (Annual MtB Business Plan Competition & MtB Call for Ideas)
- 38. Providing training & education to the new generation of entrepreneurs (MtBBootcamp and Coaching)
- 39. Showcasing the most promising startups and opening an international debate (MtB Venture Camp @ Corrieredella Sera)
- 40. Hosting&mentoring the most promising startups in the Silicon Valley (MtB Gym)
- 41. Pitching US investors / partners (MtB Gran Finale events)Connecting Talent MIND THE BRIDGE FOUNDATION Not for profit..…… 501c(3) California Independent………… fundedbydonorsnotgovernment Ecosystem.……..…… partneringwith the mostrelevantactors 6
- 42. Does Success Depend on Forces Outside Our Control?
- 44. 300+ people crowding SalaBuzzati last November
- 45. 9,000 people attending the event in streaming (40% from outside Italy)
- 46. 150+ people attending the Gran Finale at Stanford on March 18th
- 47. 100 people attending the Gran Finale in NY (Italian Consulate) on March 25th
- 48. Over 30 road-shows in Italy in the period Feb-Apr, 2010, 2.000+ students and researchers attending
- 49. 3,000+ people subscribing our Newsletter, 750+ fan on Facebook: a growing community
- 50. Blog on corriere.it (Silicon Valley) with really nice feedbacks